Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,526 | -26,778 | 4,449 | -10,532 | -2,532 |
| Depreciation Amortization | 551 | 11 | 3 | 419 | 233 |
| Accounts receivable | -79 | 39 | 766 | -605 | 657 |
| Other Working Capital | -2,171 | 392 | 3,113 | -223 | -664 |
| Other Operating Activity | 5,802 | 24,725 | -8,330 | 6,986 | -5,303 |
| Operating Cash Flow | $-10,423 | $-1,611 | $1 | $-3,955 | $-7,609 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 3,389 | N/A | -2 | -13 | -40 |
| Investing Cash Flow | $3,389 | $N/A | $-2 | $-13 | $-40 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -400 | 400 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -2,750 | -2,750 |
| Common Stock Issued | 36,052 | 12,307 | 29 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 4,654 | 5,826 |
| Financing Cash Flow | $35,652 | $12,707 | $29 | $1,904 | $3,076 |
| Beginning Cash Position | 11,520 | 424 | 396 | 2,460 | 7,033 |
| End Cash Position | 40,138 | 11,520 | 424 | 396 | 2,460 |
| Net Cash Flow | $28,618 | $11,096 | $28 | $-2,064 | $-4,573 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,423 | -1,611 | 1 | -3,955 | -7,609 |
| Capital Expenditure | -308 | N/A | -2 | -13 | -40 |
| Free Cash Flow | -10,731 | -1,611 | -1 | -3,968 | -7,649 |